Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Dividend Portfolio: IPH Ltd (ASX: IPH)
Wise-Owl Archived Feb 06, 2019
IPH Ltd protection. Services related to patent filings deliver 80% of its revenue, with the balance from trademarks. With a market share of 24%, IPH manages more patents in Australia and Singapore than any other competitor. IPH subsidiaries include Spruson & Ferguson, which has a 130-year operating history in Australia and a 21-year operating record in Asia. The Company employs over 650 people. IPH was listed on the ASX in November 2014. On 11 March 2016 IPH was included in the S&P/ASX 200 index.
Growth Portfolio: Afterpay Touch Group Ltd (APT) - Buy
Wise-Owl Archived Jan 18, 2019
Afterpay Touch Group Ltd is an Australian technology company focused on payment technologies. The Company enables retail merchants to offer their customers the ability to buy goods and services on installment plans at no extra cost to the end-user. As of November 2018, Afterpay had 2.9 million customers and 21,000 retail merchants on-boarded. The combined entity listed on the ASX in June 2017 following the merger of Afterpay Holdings Ltd and Touchcorp Ltd.
Growth Portfolio: Genetic Signatures Ltd (ASX: GSS)
Wise-Owl Archived Sep 04, 2018
Genetic Signatures Ltd . Its principal asset is IP surrounding ‘3Base’, a patented platform technology that reduces time and complexity in molecular testing by converting the original 4-base microbial genome to 3-base. The Company has commercialised this IP by launching a series of testing kits, branded ‘Easyscreen’, which identify more pathogens, 90% faster than traditional methods. Kits covering stomach bugs and influenza are approved for sale in Australia and the EU. Genetic Signatures listed on the ASX in 2015.
Growth Portfolio: ALS Limited (ALQ) - Buy
Wise-Owl Archived Aug 15, 2018
ALS Ltd is an Australian commercial services company focused on testing and quality assurance. The Company undertakes food and pharmaceutical quality assurance; mining and mineral exploration; commodity certification; equipment maintenance, and asset care operations. It operates one of the world’s largest analytical and testing services businesses in more than 50 countries with over 300 locations. The Company was founded in 1863 and listed on the ASX in 1952. The Company was previously known as Campbell Brothers. It is a member of the ASX100 index.
Growth Portfolio: Noni B Limited (ASX: NBL)
Wise-Owl Archived Aug 02, 2018
Noni B Limited is an Australian retail company focused on women’s clothing apparel and accessories. Noni B owns a portfolio of retail clothing brands distributed via a network of 1,350 stores as well as an online presence. Earlier this year, Noni B announced the acquisition of five additional brands - including Millers, Katies, Crossroads, Rivers, and Autographs – expanding its total portfolio to 9 brands. The Company was founded in 1977.